NPI registry status
Active
2026 NPPES data Urology Physician NPI 1619963535 MD
Verify on CMS → Erik Enquist, MD
Urology Physician in Westerly, Rhode Island.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,606 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 693 beneficiaries · Urology Physician avg: 1K
MIPS score
73.6/100
▼ 10 pts below national avg 83.5 · Mid-tier
Industry payments
$109.92
1 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Erik Enquist, MD reported a CMS MIPS final score of 73.6/100 - below the 83.5 national average - and filed 3,377 Medicare Part D claims in 2024.
- 73.6/100
- MIPS score · -10 vs avg
- 3K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥11th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Erik Enquist, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1619963535), first enumerated 09/26/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,377 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 73.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$109.92 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1619963535 · Urology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-BELOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1619963535
- ENUM-LEGACY 2005
- TAX-MID 14K Urology Physician
- MIPS-BELOW 73.6/100
- RX-MID 3,377
- BOOK-THIN 59 in Rhode Island
- PHOTO-FINISH Catherine Alonzo · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Enquist · this p…
Enquist · this provider
73.6 MIPS pts
- Thomas Buckley ·…
Thomas Buckley
73.6 MIPS pts
- Catherine Alonzo…
Catherine Alonzo
73.6 MIPS pts
- Angela Arlen · n…
Angela Arlen
73.6 MIPS pts
- Joseph Brito · n…
Joseph Brito
73.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Erik Enquist, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
74 ≥ 11th percentile 11% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Erik Enquist, MD sits
This provider among urology physician peers
Across the 4,091 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Erik Enquist, MD writes more Part D claims than 92% of them and scores higher on MIPS quality than 11% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one urology physician peer from a representative sample of 60; the gold marker is Erik Enquist, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Erik Enquist, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Erik Enquist, MD?
Below national averagePrimary specialty
Urology Physician
Medicare Part D claims
3,377 149% vs specialty avg
MIPS final score
73.6/100 9.9 pts vs avg
Specialty distribution in Rhode Island
How Urology Physician compares to other specialties among Rhode Island providers
Medicare quality performance, MIPS
Erik Enquist, MD's 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 73.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1619963535 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 09/26/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
73.5637
Final Score
Measured-score avg: 83.5
75.8435
Quality
51.4318
Cost
74
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Erik Enquist, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Northeast Medical Group Inc
Westerly, RI
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Erik Enquist, MD. Source: openpaymentsdata.cms.gov.
Total received
$110
Largest payer
PROGENICS PHARMACEUTICALS, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,377
Total Claims
$260K
Total Drug Cost
693
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,244.6
- Total Day Supply
- 175,620
- Generic Drug Cost
- $71K
- Opioid Claims
- 11 (0.3% rate)
- Antibiotic Claims
- 1,029
Patient Demographics
- Average Patient Age
- 76.8 years
- Avg HCC Risk Score
- 1.52
- Gender Split
- 27% female / 73% male
- Age Distribution
- <65: 33, 65-74: 246, 75-84: 282, 85+: 132
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Erik Enquist, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tamsulosin Hcl
Tamsulosin Hcl
840 claims
- Sulfamethoxazole-T… 267
Sulfamethoxazole-Trimethoprim
267 claims
- Oxybutynin Chloride 255
Oxybutynin Chloride
255 claims
- Nitrofurantoin 240
Nitrofurantoin
240 claims
- Cephalexin 218
Cephalexin
218 claims
- Ciprofloxacin Hcl 213
Ciprofloxacin Hcl
213 claims
- Finasteride 210
Finasteride
210 claims
- Gemtesa 163
Gemtesa
163 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 840 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 267 |
| Oxybutynin Chloride | 255 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 240 |
| Cephalexin | 218 |
| Ciprofloxacin Hcl | 213 |
| Finasteride | 210 |
| Gemtesa Vibegron | 163 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 148 |
| Myrbetriq Mirabegron | 109 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Erik Enquist, MD fits within the Urology Physician landscape nationally.
13,606
Urology Physician Providers in US
54
States with Urology Physician
1,354
Avg Claims per Provider
Erik Enquist, MD's 3,377 claims are above the specialty average of 1,354.
Nationwide Urology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Enquist, both outside Rhode Island so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (73.6 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urology Physician Providers in Rhode Island
Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Enquist.
One of 59 Urology Physician providers enrolled in Rhode Island, 5 are shown here.
Dr. Shadi Al Ekish
M.D.
Providence, RI
Dr. Michael Alavian
M.D.
Johnston, RI
Dr. Ashley Alford
MD
Newport, RI
Dr. Mariepet Ask
M.D.
Providence, RI
Dr. Lawrence Audino
M.D.
Portsmouth, RI
Compare Urology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Erik Enquist, MD's specialty? ▼
Erik Enquist, MD specializes in Urology Physician and practices in Westerly, Rhode Island. Credentials: MD.
How much does Erik Enquist, MD prescribe under Medicare Part D? ▼
In 2024, Erik Enquist, MD wrote 3,377 Medicare Part D claims totaling $260K in drug costs for 693 beneficiaries.
What is Erik Enquist, MD's Medicare quality score? ▼
Erik Enquist, MD has a CMS MIPS Final Score of 73.6/100 (Quality: 75.8, Cost: 51.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Erik Enquist, MD located? ▼
Erik Enquist, MD is located at 35 WELLS ST, Westerly, RI, 02891. Phone: (401) 596-0964.
What is Erik Enquist, MD's NPI number? ▼
Erik Enquist, MD's National Provider Identifier (NPI) is 1619963535, issued on 09/26/2005.
Does Erik Enquist, MD prescribe opioids? ▼
Yes, Erik Enquist, MD had 11 opioid claims in 2024 with an opioid prescribing rate of 0.3%.
How many Urology Physician providers are there in the US? ▼
There are 13,606 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,354 Medicare Part D claims per year.
What drugs does Erik Enquist, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Erik Enquist, MD's most frequently prescribed drugs include Tamsulosin Hcl, Sulfamethoxazole-Trimethoprim, Oxybutynin Chloride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Erik Enquist, MD accept Medicare? ▼
Erik Enquist, MD appears in CMS Medicare data with 3,377 Part D claims and 693 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Erik Enquist, MD's credentials? ▼
Erik Enquist, MD's NPI is 1619963535 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.